MTPC: Profits Down but Remicade, Generics Show Steady Growth in Apr-Sept

November 1, 2011
In its consolidated settlement of accounts for April-September announced on October 31, Mitsubishi Tanabe Pharma Corporation (MTPC)’s sales decreased ¥4.3 billion compared to the corresponding period of the previous year due to the rebound from temporary increases in orders at...read more